Pegylated liposomal doxorubicin in the treatment of mycosis fungoides [3]

Acta Dermato-Venereologica

Volumn 86, Issue 6, 2006, Pages 545-547

  Lybaek, Dorte ^a   Iversen, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN DERIVATIVE; CHLORAMBUCIL; CHLORMETHINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETRETIN; METHOTREXATE; STEROID;

ADULT; AGED; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; ELECTRON THERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LETTER; MALE; MULTIPLE CYCLE TREATMENT; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PUVA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DOXORUBICIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; POLYETHYLENE GLYCOLS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 33845640145     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0133     Document Type: Letter

References (11)

1. Diamandidou E, Cohen PR, Kurtzrock R. Mycosis fungoides and Sézary syndrome. Blood 1996; 88: 2385-2409.
2. Whittaker SJ, Marsden JR, Spittle M, Russel Jones R. Joint British Association of Dermatologists and UK Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003; 149: 1095-1107.
3. Dummer R. Emerging drugs in cutaneous T-cell lymphomas. Expert Opin Emerg Drugs. 2005; 10: 381-392.
4. Hotobàgyi GN. Anthracyclines in the treatment of cancer: an overview. Drugs 1997; 54 (suppl) 1-7.
5. Crawford J. Clinical uses of pegylated pharmaceuticals in oncology. Cancer Treat Rev 2002; 28 (suppl): 7-11.
6. Wollina U, Dummer R, Brockmeyer NH, Konrad H, Busch JO, Kaatz M, et al. Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma. Cancer 2003; 98: 993-1001.
7. Di Lorenzo G, Di Trolio R, Delfino M, De Placido S. Pegylated liposomal doxorubicin in stage IVB mycosis fungoides. Br J Dermatol. 2005; 153: 183-185.
8. Wollina U, Graefe T, Krate K. Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin. J Am Acad Dermatol 2000; 42: 40-46.
9. Tsatalas C, Martinis G, Margaritis D, Spanoudakis E, Kotsianidis I, Karpouzis A, Bourikas G. Long-term remission of recicalcitrant tumour-stage mycosis fungoides following chemotherapy with pegylated liposomal doxorubicin. J Eur Acad Dermatol Venereol 2003; 17, 80-82.
10. Prince HM, Seymour JF, Ryan G, McCormack C. Pegylated liposomal doxorubicin in the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 2001; 44: 149-150.
11. Kerl H, Sterry W. Classification and staging. In: Burg G, Sterry W, eds. EORTC/BMFT Cutaneous Lymphoma Project Group: recommendations for staging and therapy of cutaneous lymphomas. Berlin: Springer, 1987: p. 1-10.